Pfizer Secures $5 Billion From US Government for 10 Million Courses of COVID-19 Pill

Paxlovid, Pfizer's COVID-19 pill, is seen manufactured in Ascoli, Italy, in an undated photograph. Pfizer via Reuters

U.S. government officials have reached an agreement with Pfizer that secures 10 million courses of the drugmaker’s COVID-19 pill.

The government is paying $5.3 billion, or $529 a course for the pill.